Illumina, Inc.

NASDAQ:ILMN

100.8 (USD) • At close July 3, 2025
Bedrijfsnaam Illumina, Inc.
Symbool ILMN
Munteenheid USD
Prijs 100.8
Beurswaarde 15,956,640,000
Dividendpercentage 0%
52-weken bereik 68.7 - 156.66
Industrie Diagnostics & Research
Sector Healthcare
CEO Mr. Jacob Thaysen Ph.D.
Website https://www.illumina.com

An error occurred while fetching data.

Over Illumina, Inc.

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company

Vergelijkbare Aandelen

Walgreens Boots Alliance, Inc. logo

Walgreens Boots Alliance, Inc.

WBA

11.47 USD

IDEXX Laboratories, Inc. logo

IDEXX Laboratories, Inc.

IDXX

547.01 USD

Biogen Inc. logo

Biogen Inc.

BIIB

132.87 USD

DexCom, Inc. logo

DexCom, Inc.

DXCM

82.93 USD

Royalty Pharma plc logo

Royalty Pharma plc

RPRX

36.37 USD

Seagen Inc. logo

Seagen Inc.

SGEN

228.74 USD

Moderna, Inc. logo

Moderna, Inc.

MRNA

30.49 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)